In spite of considerable achievements, treatment of established lupus is a difficult task. Complete remission of mild disease with mucocutaneus or joint disease remains a challenge with a ...

Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

The clinical hold doesn’t cover its drug’s Investigational New Drug application for autoimmune hepatitis, for which the Phase ...

The US FDA has imposed a clinical hold on Kezar Life Sciences’ IND application for zetomipzomib, aimed at treating lupus ...

Clinical research has shown that patients with systemic lupus erythematosus (SLE) are more likely to develop cardiovascular ...

Earlier this month, Kezar Life Sciences announced that the mid-stage test of zetomipzomib in lupus nephritis had been placed ...

Thousands of passionate people with lupus and those who care about the cause will join together Saturday, October 19 at the ...

Completes Transition to Immune-Mediated Disease Focused CompanyHighlights Additional Data from Phase 1b Primary Membranous ...

A new study suggests that your morning cup of coffee might do more than just wake you up – it could be giving your blood ...

The regulator's decision came after the company paused the study in September to review safety data following the deaths of ...

Panelists discuss the differences in efficacy and safety profiles between belimumab and voclosporin for lupus nephritis (LN) and how payers are evaluating their value, including considerations of cost ...

Systemic lupus erythematosus is associated with substantial morbidity and involves major organs including the kidneys and the CNS. Based on randomized, controlled trials and long-term ...